$2.39
-0.02-0.83%
At close: -
$2.39
0.000.00%
After Hours: Jun 20, 4:32 PM EDT
Comments
Loading...
Ambev Analyst Ratings and Price Targets | NYSE:ABEV | Benzinga
Ambev SA has a consensus price target of $2.94 based on the ratings of 8 analysts. The high is $3.74 issued by Bernstein on May 24, 2023. The low is $2.5 issued by Barclays on May 12, 2025. The 3 most-recent analyst ratings were released by UBS, Barclays, and Barclays on June 4, 2025, May 12, 2025, and January 21, 2025, respectively. With an average price target of $2.4 between UBS, Barclays, and Barclays, there's an implied 0.42% upside for Ambev SA from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Barclays
UBS
Jefferies
Bernstein
1calculated from analyst ratings
Analyst Ratings for Ambev
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/04/2025 | Buy Now | 12.97% | UBS | Rodrigo Alcantara48% | $2.6 → $2.7 | Maintains | Neutral | Get Alert |
| 05/12/2025 | Buy Now | 4.6% | Barclays | Benjamin Theurer61% | $2 → $2.5 | Maintains | Equal-Weight | Get Alert |
| 04/22/2025 | Buy Now | — | UBS | Rodrigo Alcantara48% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/07/2025 | Buy Now | — | Morgan Stanley | — | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 01/22/2025 | Buy Now | — | Citigroup | Renata Cabral60% | — | Downgrade | Buy → Neutral | Get Alert |
| 01/21/2025 | Buy Now | -16.32% | Barclays | Benjamin Theurer61% | $2.5 → $2 | Maintains | Equal-Weight | Get Alert |
| 07/31/2024 | Buy Now | 21.34% | UBS | — | $3.2 → $2.9 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | 4.6% | Barclays | Benjamin Theurer61% | $3 → $2.5 | Maintains | Equal-Weight | Get Alert |
| 03/04/2024 | Buy Now | 25.52% | Barclays | Benjamin Theurer61% | $3.5 → $3 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/22/2023 | Buy Now | 19.67% | Jefferies | Alex Wright14% | → $2.86 | Initiates | → Hold | Get Alert |
| 05/24/2023 | Buy Now | 56.49% | Bernstein | Nadine Sarwat36% | → $3.74 | Initiates | → Outperform | Get Alert |
| 07/13/2022 | Buy Now | — | JP Morgan | Lucas Ferreira39% | — | Upgrade | Neutral → Overweight | Get Alert |
FAQ
What is the target price for Ambev (ABEV) stock?
The latest price target for Ambev (NYSE:ABEV) was reported by UBS on June 4, 2025. The analyst firm set a price target for $2.70 expecting ABEV to rise to within 12 months (a possible 12.97% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ambev (ABEV)?
The latest analyst rating for Ambev (NYSE:ABEV) was provided by UBS, and Ambev maintained their neutral rating.
When was the last upgrade for Ambev (ABEV)?
The last upgrade for Ambev SA happened on July 13, 2022 when JP Morgan raised their price target to N/A. JP Morgan previously had a neutral for Ambev SA.
When was the last downgrade for Ambev (ABEV)?
The last downgrade for Ambev SA happened on April 22, 2025 when UBS changed their price target from N/A to N/A for Ambev SA.
When is the next analyst rating going to be posted or updated for Ambev (ABEV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ambev, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ambev was filed on June 4, 2025 so you should expect the next rating to be made available sometime around June 4, 2026.
Is the Analyst Rating Ambev (ABEV) correct?
While ratings are subjective and will change, the latest Ambev (ABEV) rating was a maintained with a price target of $2.60 to $2.70. The current price Ambev (ABEV) is trading at is $2.39, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
